BAFF-R and CD21 dysregulation inhibits memory B cell persistence in patients with common variable immunodeficiency
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Individuals with common variable immunodeficiency (CVID) are at increased risk of respiratory infections such as SARS-CoV-2 infection due to poorly understood defects within the memory B cell (MBC) compartment. The COVID-19 pandemic presented a unique opportunity to investigate the effects of a novel pathogen and vaccination on the immune system of patients with CVID.
Methods
A cross-sectional, single-center, cohort study was used to evaluate the immunologic effect of SARS-CoV-2 vaccination and/or disease on the immune system. We examined the antibody levels, neutralization capacity, MBC, and CD4 + T follicular helper cell (T FH ) response against two SARS-CoV-2 variants in 23 CVID patients and 51 age- and sex-matched healthy individuals with both vaccine-induced and hybrid immunity across multiple immunization events.
Results
Our study shows that while CVID patients mount a sufficient CD4 + T FH response against both ancestral and Omicron variants, and some levels of neutralizing antibodies, Spike-specific MBC formation is severely inhibited. Only CVID patients with hybrid immunity were able to generate switched MBCs against both variants. These MBCs were transient however, as Spike-specific switched MBCs did not persist over time in CVID patients. We found that the level of switched MBCs correlated with both CD21 and BAFF-R expression in patients, many of whom expressed low levels of either receptor.
Conclusion
Taken together, our study shows that CVID patients generate a sufficient CD4 + T FH response against SARS-CoV-2 but rarely cross-reactive MBCs, and suggest that this effect is correlated with CD21 and BAFF-R dysregulation which might cause switched MBC obsolescence.
Trial registration
21/54057.
Funding
Lundbeck Foundation, Novo Nordisk Foundation and Odense University Hospital.
